CASSS cultivates a global community
of industry, academic and regulatory professionals to work together to resolve scientific challenges in the field of biopharmaceutical development and regulation.
I want to:
Upcoming Events
-
CMC Strategy Forum ChinaAugust 23 to 24, 2022 -
DC Discussion GroupSeptember 14, 2022 -
CE in the Biotechnology & Pharmaceutical IndustriesSeptember 18 to 21, 2022 -
Practical Applications of Mass Spectrometry in the Biotechnology IndustrySeptember 27 to 30, 2022 -
The Netherlands Area Biotech Discussion GroupOctober 6, 2022
-
CMC Strategy Forum EuropeOctober 17 to 19, 2022 -
CMC Strategy Forum JapanDecember 5 to 6, 2022 -
CMC Strategy Forum North AmericaJanuary 23, 2023 -
WCBPJanuary 24 to 26, 2023 -
Bioassays: Scientific Approaches & Regulatory StrategiesApril 17 to 19, 2023 -
Analytical Technologies EuropeMay 9 to 12, 2023 -
Latest CASSS News
National Minority Donor Awareness Month
Aug 12, 2022
August is National Minority Donor Awareness Month (NMDAM), when we call attention to the disparities between the number of organ donors and the number of minorities, including African American, Latinx, and Asian Americans, in need of life-saving organs and tissues.
Member Spotlight: Patsy Lewis
Jul 25, 2022
The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on Patsy Lewis, Director of CMC Development-Virtual at Tonix Pharmaceuticals.
I attended Cell & Gene Therapy 2022 in person in Arlington. It was a fantastic meeting as always with excellent talks from industry SMEs as well as speakers from regulatory agencies around the globe (FDA, EU, Health Canada, etc),
great opportunity for networking as well. I really enjoyed the meeting.
— Cheng-Hong Wei Cell & Gene Therapy Products 2022